NO885738D0 - IN CELLS AMFIFILE PROTEINS PROVIDED IN Aggregate FORM AND PROCEDURE FOR THE PREPARATION AND PURIFICATION OF SUCH PROTEINS. - Google Patents

IN CELLS AMFIFILE PROTEINS PROVIDED IN Aggregate FORM AND PROCEDURE FOR THE PREPARATION AND PURIFICATION OF SUCH PROTEINS.

Info

Publication number
NO885738D0
NO885738D0 NO885738A NO885738A NO885738D0 NO 885738 D0 NO885738 D0 NO 885738D0 NO 885738 A NO885738 A NO 885738A NO 885738 A NO885738 A NO 885738A NO 885738 D0 NO885738 D0 NO 885738D0
Authority
NO
Norway
Prior art keywords
proteins
cells
purification
amfifile
procedure
Prior art date
Application number
NO885738A
Other languages
Norwegian (no)
Other versions
NO175782B (en
NO885738L (en
NO175782C (en
Inventor
Johann Eibl
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO885738D0 publication Critical patent/NO885738D0/en
Publication of NO885738L publication Critical patent/NO885738L/en
Publication of NO175782B publication Critical patent/NO175782B/en
Publication of NO175782C publication Critical patent/NO175782C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)

Abstract

Proteins produced in cells collect together to form particulate aggregates. The invention relates to the reversible conversion of said aggregated proteins into morphological forms I, II and III which differ from one another, depending on the presence or absence of a non-denaturing detergent. The invention also relates to a process for the isolation and purification of said aggregated forms of proteins produced in cells.
NO885738A 1987-12-23 1988-12-23 Process for the preparation and purification of amphiphilic proteins in aggregate form produced in cells and their use NO175782C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87119172A EP0321606B1 (en) 1987-12-23 1987-12-23 Cellular amphipatic proteins in aggregated forms, and procedure for the production and purification of these proteins

Publications (4)

Publication Number Publication Date
NO885738D0 true NO885738D0 (en) 1988-12-23
NO885738L NO885738L (en) 1989-06-26
NO175782B NO175782B (en) 1994-08-29
NO175782C NO175782C (en) 1994-12-07

Family

ID=8197541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885738A NO175782C (en) 1987-12-23 1988-12-23 Process for the preparation and purification of amphiphilic proteins in aggregate form produced in cells and their use

Country Status (8)

Country Link
EP (1) EP0321606B1 (en)
JP (1) JP2656098B2 (en)
AT (1) ATE95188T1 (en)
DE (1) DE3787654D1 (en)
DK (1) DK628188A (en)
ES (1) ES2059355T3 (en)
FI (2) FI96864C (en)
NO (1) NO175782C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672895B1 (en) * 1991-02-15 1995-05-12 Transgene Sa PROCESS FOR THE PURIFICATION OF A HIGHLY GLYCOSYLATED PROTEIN.
FR2692898B1 (en) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Method for obtaining membrane proteins, and use of these proteins for diagnostic or vaccination purposes.
US5914390A (en) * 1997-05-12 1999-06-22 Celtrix Pharmaceuticals, Inc. Methods for increasing yields of recombinant proteins
DE19939246A1 (en) 1999-08-19 2001-02-22 Phasys Gmbh M Refolding membrane proteins into their native or active form comprises solubilizing the protein in a first detergent and replacing the first detergent with a second detergent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61233700A (en) * 1984-12-24 1986-10-17 ジエネンテク，インコ−ポレイテツド Molecularly cloned aids related polypeptide
CN86100979A (en) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 The preparation method of malaria vaccine
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
JPS62198627A (en) * 1986-02-26 1987-09-02 Biseibutsu Kagaku Kenkyusho:Kk Aujesky's disease solubilizing antigen vaccine

Also Published As

Publication number Publication date
NO175782B (en) 1994-08-29
FI953141A0 (en) 1995-06-22
ES2059355T3 (en) 1994-11-16
FI885629A0 (en) 1988-12-02
JP2656098B2 (en) 1997-09-24
FI885629A (en) 1989-06-24
JPH02798A (en) 1990-01-05
FI96864B (en) 1996-05-31
NO885738L (en) 1989-06-26
DK628188D0 (en) 1988-11-10
DE3787654D1 (en) 1993-11-04
NO175782C (en) 1994-12-07
EP0321606B1 (en) 1993-09-29
FI97058B (en) 1996-06-28
ATE95188T1 (en) 1993-10-15
DK628188A (en) 1989-06-24
FI953141A (en) 1995-06-22
FI97058C (en) 1996-10-10
FI96864C (en) 1996-09-10
EP0321606A1 (en) 1989-06-28

Similar Documents

Publication Publication Date Title
NO884561D0 (en) PROCEDURE FOR CONVERTING METANE TO HIGHER HYDROCARBONES.
DE3787446D1 (en) Multi-layer ceramics based on silicate esters.
DE3784157D1 (en) MODIFIED SUCCINIMIDES.
NO855018L (en) PROCEDURE FOR CONVERTING METANE TO HIGHER HYDROCARBONES.
NO870679D0 (en) PROTECTED ENZYME SYSTEM FOR USE IN DETERGENTS.
DE69018765D1 (en) Power convertible top for convertible.
DE3583930D1 (en) CLEANING OF SOLUTIONS TO THE BAYER PROCESS.
NO874108D0 (en) PROCEDURE FOR REFINING SILICON AND SILICON CLEANED BY PROCEDURE.
DE3684469D1 (en) DOCUMENT PROCESSING PLANT.
IT1216852B (en) PROCEDURE AND PLANT FOR THE PURIFICATION OF RESIDUAL WATERS, IN PARTICULAR OF URBAN RESIDUAL WATERS.
ATE114713T1 (en) BIOMASS FOR PRODUCTION OF VIRUS/VIRUS ANTIGEN.
NO885738L (en) IN CELLS AMFIFILE PROTEINS PROVIDED IN Aggregate FORM AND PROCEDURE FOR THE PREPARATION AND PURIFICATION OF SUCH PROTEINS.
DK545484A (en) 2,5-DIKETO-D-GLUCONIC ACID REDUCTASE
KR880701762A (en) Process for surface Treating Layered Lattice.Silicates and Resultant Products
DE3485210D1 (en) IMMOBILIZED ENZYME COMPOSITIONS.
NO873943D0 (en) PROCEDURE FOR CLEANING TPA.
DE69014644D1 (en) SOMATIC EMBRYOGENESIS OF PUMPKINS.
PH22964A (en) Improved fermentation process for producing angiotensin i converting enzyme inhibitor a-58365 factor b.
DK600187A (en) PROCEDURE FOR PROMOTING SEPARATION OF AMYLOLYTIC ENZYMES FROM BACTERIA AND ENZYMES OBTAINED BY THE PROCEDURE
DE3673387D1 (en) COUPLING PIECE FOR CONNECTING CONTAINERS.
MA21068A1 (en) PROCESS FOR THE PREPARATION OF AN ANGIOTENSIN CONVERSION ENZYME INHIBITOR COMPOSITION.
NO880576L (en) PROCEDURE FOR AA IMPROVING CERAMIC CHAMBLE BEAMS.
IT1178489B (en) CLONANT VECTOR, PROCEDURE FOR ITS CONSTRUCTION AND CONCENTRATION AND PURIFICATION PROCEDURE OF PRODUCED PROTEINS, FORMED BY THE CLONANT VECTOR
FR2557457B1 (en) PROCESS FOR THE PREPARATION OF THE TUBERCULINIC ANTIGEN L.
ATE56260T1 (en) COUPLING FOR COUPLING PIPE PARTS.